NovoCure Ltd (NAS:NVCR)
$ 16.62 0.03 (0.18%) Market Cap: 1.80 Bil Enterprise Value: 1.51 Bil PE Ratio: 0 PB Ratio: 4.98 GF Score: 67/100

Q1 2020 Novocure Ltd Earnings Call Transcript

Apr 30, 2020 / 12:00PM GMT
Release Date Price: $65.8 (-10.52%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the NovoCure First Quarter 2020 Earnings Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded. (Operator Instructions).

I would now like to hand the conference to your speaker today, Ashley Cordova, Senior Vice President of Finance and Investor Relations. Please go ahead, ma'am.

Ashley Cordova
NovoCure Limited - VP of Finance & IR

Good morning, everyone, and thank you for joining us to review NovoCure's first quarter 2020 performance. On behalf of the entire NovoCure team, we would like to begin by wishing you well as we collectively face the challenges of the COVID-19 pandemic. We hope that you and your loved ones are staying healthy and safe during this unprecedented time.

With safety in mind, we are conducting today's call virtually. I am joined on the phone by our Executive Chairman, Bill Doyle; our CEO, Asaf Danziger; and our CFO, Wilco Groenhuysen. Pritesh Shah, our Chief Commercial Officer; and Ely Benaim, our Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot